COVID-19, Pneumothorax
Conditions
Keywords
COVID-19, pneumothorax
Brief summary
It is aimed to examine the retrospective features of covid-19 patients followed in our hospital with pneumothorax.
Detailed description
It is aimed to examine the retrospective features of covid-19 patients followed in our hospital with pneumothorax. The files of covid-19 patients with pneumothorax were reviewed retrospectively. The radiological records and treatment protocols of the patients were reviewed. The results were evaluated in terms of its relationship with pneumothorax.
Interventions
None listed
Sponsors
Erol Olcok Corum Training and Research Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* over 18 years * covid-19 patient * having a diagnosis of pneumothorax * PCR test positive and lung tomography pneumonic involvement
Exclusion criteria
* PCR test negative
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| relationship between covid-19 and pneumothorax | 1 year | Inflammatory markers, C-reactive protein (CRP), lactate dehydrogenase (LDH), ferritin, D-dimer, procalcitonin, blood gas lactate, creatine kinase, white blood cells, baseline laboratory test results including WBC, lymphocyte, neutrophil counts, platelets, urea, creatinine, and neutrophil/lymphocyte ratio were documented for each patient. Respiratory support status, the fraction of inspired oxygen (FiO2), positive end-expiratory pressure (PEEP) values, tidal volume, and duration of the mechanical ventilator (MV) stay were determined. |
Countries
Turkey (Türkiye)
Outcome results
None listed